Market Leads & Opportunities
Covid-19: First nasal spray for treating adult patients launched in India
Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from Covid-19.Glenmark received manufacturing and marketing approval from India’s drug regulator, Drugs Controller General of India, for Nitric Oxide Nasal Spray as part of the accelerated approval process.The company claims that when the Nitric Oxide Nasal is sprayed over nasal mucosa it acts as a physical and chemical barrier against the virus.Terming the spray an effective and safe antiviral treatment for Covid-19, Glenmark Pharmaceuticals Ltd’s Chief Commercial Officer Robert Crockart said “we are confident it will offer patients a much needed and timely therapy option.”
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre. - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million.
- In association with::
